Literature DB >> 17534626

The impact of obesity on prostate cancer.

Joep G H van Roermund1, J Alfred Witjes.   

Abstract

Increasing prevalence of obesity in many parts of the world emphasizes the importance of learning more about the relationship between obesity and prostate cancer (PC). The present paper reviews the impact of obesity on PC using knowledge obtained from the available literature. Search of published literature in PUBMED database. Adipose tissue constitutes an active endocrine and metabolic organ which may be relevant in the development and progression of PC by different potential mechanisms. Furthermore, obesity could have an impact on the outcome of different treatment modalities for PC, both functionally as anatomically. Obesity is a growing problem, however, the exact role in the development and progression of PC has not been elucidated. Regarding the optimal treatment of PC in obese patients, comparative prospective studies are needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534626     DOI: 10.1007/s00345-007-0178-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  59 in total

1.  Prostate cancer risk and serum levels of insulin and leptin: a population-based study.

Authors:  A W Hsing; S Chua; Y T Gao; E Gentzschein; L Chang; J Deng; F Z Stanczyk
Journal:  J Natl Cancer Inst       Date:  2001-05-16       Impact factor: 13.506

2.  Relationship between body mass index and prostate cancer screening in the United States.

Authors:  Charles D Scales; Lesley H Curtis; Regina D Norris; Kevin A Schulman; Philipp Dahm; Judd W Moul
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

3.  Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.

Authors:  Stephen J Freedland; Elizabeth A Platz; Joseph C Presti; William J Aronson; Christopher L Amling; Christopher J Kane; Martha K Terris
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

4.  Obesity and prostate cancer screening in the USA.

Authors:  K R Fontaine; M Heo; D B Allison
Journal:  Public Health       Date:  2005-01-19       Impact factor: 2.427

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 6.  Hormones and prostate cancer: current perspectives and future directions.

Authors:  Ann W Hsing; Juergen K V Reichardt; Frank Z Stanczyk
Journal:  Prostate       Date:  2002-08-01       Impact factor: 4.104

7.  Body mass index and risk of prostate cancer in U.S. health professionals.

Authors:  Edward Giovannucci; Eric B Rimm; Yan Liu; Michael Leitzmann; Kana Wu; Meir J Stampfer; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

8.  Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

Authors:  Stephen J Freedland; William J Aronson; Christopher J Kane; Joseph C Presti; Christopher L Amling; David Elashoff; Martha K Terris
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544

Review 9.  The obesity epidemic, metabolic syndrome and future prevention strategies.

Authors:  Philip T James; Neville Rigby; Rachel Leach
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2004-02
View more
  8 in total

Review 1.  Risk-based prostate cancer screening: who and how?

Authors:  Allison S Glass; K Clint Cary; Matthew R Cooperberg
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

Review 2.  Risk-based prostate cancer screening.

Authors:  Xiaoye Zhu; Peter C Albertsen; Gerald L Andriole; Monique J Roobol; Fritz H Schröder; Andrew J Vickers
Journal:  Eur Urol       Date:  2011-11-24       Impact factor: 20.096

3.  Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk.

Authors:  Sarah J Lewis; Ali Murad; Lina Chen; George Davey Smith; Jenny Donovan; Tom Palmer; Freddie Hamdy; David Neal; J Athene Lane; Michael Davis; Angela Cox; Richard M Martin
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

4.  Protein energy malnutrition (PEM) in cancer patients.

Authors:  Jaime Sanz Ortiz; José Andrés Moreno Nogueira; Abelardo García de Lorenzo y Mateos
Journal:  Clin Transl Oncol       Date:  2008-09       Impact factor: 3.405

5.  Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease.

Authors:  Naief Dahran; Magdalena Szewczyk-Bieda; Cheng Wei; Sarah Vinnicombe; Ghulam Nabi
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

6.  Body composition and pelvic fat distribution are associated with prostate cancer aggressiveness and can predict biochemical recurrence.

Authors:  Yu-Hsuan Chien; Ming-Li Hsieh; Ting-Wen Sheng; Ying-Hsu Chang; Li-Jen Wang; Cheng-Keng Chuang; See-Tong Pang; Chun-Te Wu; I-Hung Shao
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

7.  Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness.

Authors:  Joep G H van Roermund; Gijsbert H Bol; J Alfred Witjes; J L H Ruud Bosch; Lambertus A Kiemeney; Marco van Vulpen
Journal:  World J Urol       Date:  2009-12-22       Impact factor: 4.226

8.  Can robotic assisted laparoscopic prostatectomy be recommended to obese patients?

Authors:  Laura E Crocitto; Martina Ly; Roger Satterthwaite; Timothy Wilson; Rebecca A Nelson
Journal:  J Robot Surg       Date:  2008-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.